Nuestra página de facturación está certificada por:
Datos de interés
Utilidad de Merck supera expectativas por control de costos - El Economista.com.mx
Cinco DíasUtilidad de Merck supera expectativas por control de costosEl Economista.
Merck CEO: Generic Singulair, uncertain economy to make 2012-13 ... - Washington Post
Merck CEO: Generic Singulair, uncertain economy to make 2012-13 .
Merck CEO: Generic Singulair, uncertain economy to make 2012-13 ... - Washington Post
Merck CEO: Generic Singulair, uncertain economy to make 2012-13 .
La gran industria ha perdido 180.000 empleos desde 2007 - El Global
La gran industria ha perdido 180.
Merck Beats As Singulair Rakes In The Cash, But Patents Expire Soon - Forbes
Kansas City StarMerck Beats As Singulair Rakes In The Cash, But Patents Expire SoonForbesMerck's first quarter earnings narrowly beat expectations, as the company continues to juice its blockbuster drug, Singulair.